Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Hepatorenal syndrome
ADR ID BADD_A02051
ADR Hierarchy
09      Hepatobiliary disorders
09.01      Hepatic and hepatobiliary disorders
09.01.03      Hepatic failure and associated disorders
09.01.03.007      Hepatorenal syndrome
20      Renal and urinary disorders
20.01      Renal disorders (excl nephropathies)
20.01.03      Renal failure and impairment
20.01.03.012      Hepatorenal syndrome
Description Functional KIDNEY FAILURE in patients with liver disease, usually LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL), and in the absence of intrinsic renal disease or kidney abnormality. It is characterized by intense renal vasculature constriction, reduced renal blood flow, OLIGURIA, and sodium retention. [MeSH]
MedDRA Code 10019846
MeSH ID D006530
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Hepatorenal syndrome | Syndrome hepatorenal | Hepatorenal Syndrome | Syndrome, Hepatorenal
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00349Capecitabine0.000208%
BADD_D00564Dabigatran etexilate0.000550%
BADD_D00580Dapsone0.000837%
BADD_D00594Deferasirox0.001521%
BADD_D00623Dexamethasone0.000179%
BADD_D00774Entecavir--
BADD_D00800Erlotinib--
BADD_D00858Everolimus0.000190%
BADD_D00871Felbamate--
BADD_D00879Fentanyl--
BADD_D00880Fentanyl citrate--
BADD_D01009Gemcitabine0.000139%
BADD_D01120Ibuprofen--
BADD_D01181Iopamidol--
BADD_D01186Ioversol--
BADD_D01242Lamivudine0.001210%
BADD_D01336Macitentan0.000226%
BADD_D01368Mefenamic acid--
BADD_D01401Metformin0.000027%
BADD_D01592Obeticholic acid0.001097%
BADD_D01864Propofol0.000206%
BADD_D01888Quetiapine0.000100%
BADD_D01933Ribavirin0.021284%
BADD_D01938Rifaximin0.000384%
BADD_D01951Risperidone0.000140%
BADD_D01954Rivaroxaban0.001071%
BADD_D02026Simvastatin0.000028%
BADD_D02029Sitagliptin0.000065%
BADD_D02053Sofosbuvir0.002642%
BADD_D02058Sorafenib0.000347%
The 1th Page    1 2    Next   Last    Total 2 Pages